App (MASK-air) deployed in 23 countries: TRL9 (Technology Readiness level), Electronic clinical decision support system (ARIA e-CDSS): TRL 7, e-physician questionnaire deployed in 16 countries: TRL9 |
5-year work |
App: 26,000 users, 23 countries, 17 languages |
GDPR including geolocation [105] |
GP of the EIP on AHA, follows CHRODIS [14] |
Based on 11 EU grants (MeDALL [106], GA2LEN [107]) including—in 2018—POLLAR [4], VIGOUR, DigitalHealthEurope and Euriphi |
From a validated “research” tool (2004-2018) to large scale deployment (2019–) |
Validation with COSMIN guidelines [40] |
Baseline characteristics [12] |
EQ-5D [43] |
Novel phenotypes of allergic diseases [44] |
Adherence to treatment and novel approaches to inform the efficacy of treatment [45]. |
Patient’s organizations and scientific societies involved |
GARD (WHO alliance) |
Presented during WHO and EU ministerial meetings |
Next-generation care pathways meeting (Dec 3, 2018) with the EIP on AHA, POLLAR (EIT Health) and GARD |
Dissemination according to the EIP on AHA [26] |
Transfer of innovation (TWINNING [110]) |
Interoperable platform with MASK |
25 RS plus Argentina, Australia, Brazil, Canada, Mexico [99, 108, 109] |
700 patients enrolled |
GDPR solutions being solved |
Interoperable platform with MASK |
Based on an expert meeting |
Electronic version available |
GDPR solutions being solved |
Developments |
App for home services |
App for sleep |
App for COPD |
App for other chronic diseases |